Phreesia Inc. (PHR) Misses Q3 EPS by 8c, Revenues Beat

Phreesia Inc. (NYSE: PHR) reported Q3 EPS of ($0.17), $0.08 worse than the analyst estimate of ($0.09). Revenue for the quarter came in at $38.5 million versus the consensus estimate of $35.56 million.

Fiscal Third Quarter 2021 Highlights

• Revenue was $38.5 million in the quarter as compared to $32.8 million in the same period in the prior year, an increase of 17%.
• Average number of provider clients was 1,737 in the quarter as compared to 1,573 in the same period in the prior year, an increase of 10%.
• Average revenue per provider client was $17,490 in the quarter compared to $16,637 in the same period in the prior year, an increase of 5%.
• Adjusted EBITDA was positive $1.2 million in the quarter compared to positive $3.0 million in the same period in the prior year.
• Cash and cash equivalents as of October 31, 2020 was $254.1 million, an increase of $163.8 million compared to January 31, 2020, driven primarily by our follow-on offering of common stock, which generated net proceeds of $174.5 million.

"Our third quarter results reflect our entire team’s commitment to our clients and Phreesia's mission of creating a better, more engaging healthcare experience,” said Phreesia CEO Chaim Indig.

For earnings history and earnings-related data on Phreesia Inc. (PHR) click here.

You May Also Be Interested In

• American Express (AXP) down despite beating Q1 estimates on top and bottom lines
• MetroCity Bankshares, Inc. (MCBS) Tops Q1 EPS by 4c
• Procter & Gamble (PG) revenue falls short of expectations, raises full-year earnings guidance